Wall Street analysts expect Dolby Laboratories, Inc. (NYSE:DLB) to post sales of $299.35 million for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for Dolby Laboratories’ earnings, with the lowest sales estimate coming in at $297.52 million and the highest estimate coming in at $302.01 million. Dolby Laboratories posted sales of $267.47 million during the same quarter last year, which suggests a positive year over year growth rate of 11.9%. The business is scheduled to issue its next earnings report on Wednesday, April 25th.

On average, analysts expect that Dolby Laboratories will report full-year sales of $299.35 million for the current financial year, with estimates ranging from $1.16 billion to $1.18 billion. For the next fiscal year, analysts anticipate that the firm will post sales of $1.25 billion per share, with estimates ranging from $1.23 billion to $1.26 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that follow Dolby Laboratories.

Dolby Laboratories (NYSE:DLB) last released its earnings results on Wednesday, January 24th. The electronics maker reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.35. Dolby Laboratories had a net margin of 6.06% and a return on equity of 12.02%. The business had revenue of $287.80 million during the quarter, compared to analysts’ expectations of $265.75 million. During the same period last year, the business earned $0.66 earnings per share. The firm’s revenue was up 8.1% on a year-over-year basis.

DLB has been the subject of several analyst reports. B. Riley reissued a “buy” rating and issued a $65.50 target price on shares of Dolby Laboratories in a research note on Thursday, October 26th. Zacks Investment Research cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, January 3rd. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Dolby Laboratories from $63.00 to $70.00 and gave the stock a “neutral” rating in a research report on Thursday, January 25th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the stock. Dolby Laboratories currently has an average rating of “Hold” and an average target price of $62.00.

Dolby Laboratories (DLB) traded up $2.25 during trading hours on Friday, hitting $62.44. 554,896 shares of the company traded hands, compared to its average volume of 453,858. Dolby Laboratories has a twelve month low of $48.00 and a twelve month high of $74.29. The company has a market capitalization of $6,180.00, a PE ratio of 99.11, a PEG ratio of 5.07 and a beta of 0.78.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 14th. Shareholders of record on Monday, February 5th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, February 2nd. This represents a $0.64 dividend on an annualized basis and a yield of 1.02%. Dolby Laboratories’s dividend payout ratio (DPR) is 101.59%.

In other news, SVP Bob Borchers sold 116,821 shares of Dolby Laboratories stock in a transaction on Friday, November 17th. The stock was sold at an average price of $61.15, for a total transaction of $7,143,604.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director N William Jasper, Jr. sold 20,000 shares of Dolby Laboratories stock in a transaction on Monday, January 29th. The stock was sold at an average price of $66.72, for a total value of $1,334,400.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 761,989 shares of company stock valued at $47,521,183. Company insiders own 43.74% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the company. Intl Fcstone Inc. acquired a new stake in shares of Dolby Laboratories during the second quarter worth $345,000. Schroder Investment Management Group acquired a new stake in shares of Dolby Laboratories during the third quarter worth $35,761,000. Vanguard Group Inc. lifted its holdings in shares of Dolby Laboratories by 2.2% during the second quarter. Vanguard Group Inc. now owns 4,725,496 shares of the electronics maker’s stock worth $231,360,000 after buying an additional 103,702 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Dolby Laboratories by 0.5% during the second quarter. Dimensional Fund Advisors LP now owns 536,657 shares of the electronics maker’s stock worth $26,276,000 after buying an additional 2,648 shares in the last quarter. Finally, Highbridge Capital Management LLC acquired a new stake in shares of Dolby Laboratories during the third quarter worth $254,000. 52.74% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “Dolby Laboratories, Inc. (DLB) Expected to Post Quarterly Sales of $299.35 Million” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://theolympiareport.com/2018/02/12/dolby-laboratories-inc-dlb-expected-to-post-quarterly-sales-of-299-35-million.html.

About Dolby Laboratories

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Get a free copy of the Zacks research report on Dolby Laboratories (DLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.